Evidence map›Paper›PMID 27525644›Full record

ArticleTransplantation2017

Effects of Composition of Alginate-Polyethylene Glycol Microcapsules and Transplant Site on Encapsulated Islet Graft Outcomes in Mice.

Chiara Villa, Vita Manzoli, Maria M Abreu, Connor A Verheyen, Michael Seskin, Mejdi Najjar, R Damaris Molano, Yvan Torrente, Camillo Ricordi, Alice A Tomei

Open access · hybridAbstract read
In one paragraph

Article in Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Chiara Villa1 Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL. 2 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. 3 Department of Pathophysiology and Transplantation, Universitá degli Studi di Milano, Milan, Italy. 4 Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy. 5 Department of Biomedical Engineering, University of Miami, Miami, FL. 6 Department of Surgery, University of Miami Miller School of Medicine, Miami, FL. 7 Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL. 8 Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Vita Manzoli
Maria M Abreu
Connor A Verheyen
Michael Seskin
Mejdi Najjar
R Damaris Molano
Yvan Torrente
Camillo Ricordi
Alice A Tomei
University of Miami · USUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the effects of capsule composition and transplantation site on graft outcomes of encapsulated islets will aid in the development of more effective strategies for islet transplantation without immunosuppression.

methodsHere, we evaluated the effects of transplanting alginate (ALG)-based microcapsules (Micro) in the confined and well-vascularized epididymal fat pad (EFP) site, a model of the human omentum, as opposed to free-floating in the intraperitoneal cavity (IP) in mice. We also examined the effects of reinforcing ALG with polyethylene glycol (PEG). To allow transplantation in the EFP site, we minimized capsule size to 500 ± 17 μm. Unlike ALG, PEG resists osmotic stress, hence we generated hybrid microcapsules by mixing PEG and ALG (MicroMix) or by coating ALG capsules with a 15 ± 2 μm PEG layer (Double).

resultsWe found improved engraftment of fully allogeneic BALB/c islets in Micro capsules transplanted in the EFP (median reversal time [MRT], 1 day) versus the IP site (MRT, 5 days; P < 0.01) in diabetic C57BL/6 mice and of Micro encapsulated (MRT, 8 days) versus naked (MRT, 36 days; P < 0.01) baboon islets transplanted in the EFP site. Although in vitro viability and functionality of islets within MicroMix and Double capsules were comparable to Micro, addition of PEG to ALG in MicroMix capsules improved engraftment of allogeneic islets in the IP site, but resulted deleterious in the EFP site, probably due to lower biocompatibility.

conclusionsOur results suggest that capsule composition and transplant site affect graft outcomes through their effects on nutrient availability, capsule stability, and biocompatibility.

Indexed as

AlginatesAnimalsCapsulesEpididymisGlucuronic AcidHexuronic AcidsIslets of Langerhans TransplantationMaleMiceMice, Inbred BALB CMice, Inbred C57BLOmentumOutcome Assessment, Health CarePolyethylene GlycolsAlginatesCapsulesGlucuronic AcidHexuronic AcidsPolyethylene Glycols

Identifiers

PMID27525644
PMCPMC5642344
OpenAlexW2510013915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.